The Preclinical Effects and Mechanisms of Biofield Therapy on Pancreatic Cancer Cell Growth and Metastasis
Research Question: Can human Biofield Therapy (BT) physically alter the growth, spread, and underlying biology of pancreatic cancer in lab cells and animal models?
Key Findings:
- Tumor growth consistently slowed:
BT reliably suppressed the growth of multiple types of pancreatic cancer cells and patient-derived tumor organoids, with results reproduced across three different BT therapists and numerous repeated experiments. - Ability to spread (metastasis) reduced:
BT significantly reduced cancer cells' ability to migrate and invade through tissue barriers—key steps required for metastasis. - Effect appears cancer-specific:
The growth-suppressing effects were seen across cancerous cell types but not in normal pancreatic cells, suggesting BT may preferentially target tumor cells. - Mitochondrial structures visibly damaged:
Microscopy revealed that BT caused significant swelling and disruption to cancer cell mitochondria (the cell’s energy-producing structures), indicating cellular stress or dysfunction. - Cancer cells stuck in neutral:
BT increased the proportion of cancer cells in the resting (G0/G1) phase of the cell cycle, limiting their ability to divide and proliferate. - Cell electrical properties altered:
BT reduced the electrical charge (membrane potential) across cancer cell membranes by roughly 35–50% in multiple cell lines, a change associated with reduced tumor aggressiveness. - Critical growth protein suppressed:
BT reduced levels of FOXM1, a key driver of cancer growth and metastasis. When FOXM1 was genetically removed, many of BT’s effects were diminished, suggesting it plays a central mechanistic role. - Spread to liver reduced (in vivo):
In mouse models, BT substantially reduced liver tumor burden (e.g., ~70–75% fewer metastatic nodules in some experiments). - Effects independent of human placebo effect: Because these experiments were conducted in cell cultures and animal models, the findings demonstrate measurable biological changes from BT independent of human placebo effects.
Design:
- Study Type:
A series of controlled preclinical studies including repeated in vitro experiments in multiple pancreatic cancer cell lines (human and mouse), patient-derived organoids, and three independent mouse studies. - Intervention Groups:
Cancer cells and mice were assigned to: - Biofield Therapy (BT)
- Sham Control (SC) (mimicked movements without treatment intent)
- Incubator/Colony Control (untouched)
- Treatment Protocol & Dosage:
Cell cultures received single 15- or 30-minute sessions.
Mice received 30-minute sessions, three times per week, for three weeks. - Biological Samples / Population:
Multiple pancreatic cancer cell lines, patient-derived organoids, and mouse models (typically ~16–30 mice per group depending on study).
Intervention: A biofield therapy technique (Bengston Method) in which trained practitioners rapidly cycle through mental images while holding their hands approximately 6 to 24 inches away from the target (cells or animals), without physical contact.
Results:
- Overall Results:
Across multiple experiments and three different practitioners, BT significantly reduced proliferation and invasiveness of pancreatic cancer models in vitro, with consistent effects also observed in animal studies. - In Vitro Findings (Cell Culture):
BT suppressed growth across multiple pancreatic cancer cell lines and patient-derived mini-tumors while leaving normal pancreatic cells largely unaffected. It also induced cell cycle arrest and significantly reduced migration and invasion capacity. - In Vivo Findings (Mouse Studies):
Across three mouse studies, BT consistently reduced liver tumor burden and metastatic spread severity. In some measures, these effects were comparable to gemcitabine (particularly for metastasis-related outcomes), although BT did not significantly reduce primary tumor size.
Mechanistic Findings (How It May Work):
- Mitochondria in BT-treated cancer cells appeared swollen and structurally disrupted
- Cell membrane voltage was significantly reduced (hyperpolarization)
- FOXM1, a key genetic regulator of cancer growth and metastasis, was downregulated
- When FOXM1 was removed, many of BT’s anticancer effects were diminished
Discussion: Because these experiments were conducted in cell cultures and animal models, the findings demonstrate measurable biological changes independent of human placebo effects.
BT appears to influence cancer at a fundamental level, including cellular energy systems, electrical signaling, and gene regulation pathways (notably FOXM1), leading to reduced proliferation and invasiveness. These effects occur without direct physical interaction with the cells or tumors, supporting the hypothesis that biofield-based interactions may influence biological systems.
Conclusion: This study demonstrates that biofield therapy can disrupt pancreatic cancer cell behavior and reduce metastatic burden in preclinical models. While effects on primary tumor size were limited, the consistent impact on metastasis-related processes and underlying cellular mechanisms suggests BT may be a promising complementary approach worthy of further preclinical and clinical investigation.
Link to Article:
Energy-Like Somatic Experiences in Meditation
This qualitative study gathered reports from Western Buddhist meditators, 62% of whom described energy-like sensations such as warmth, vibration “cascading through the body”, or internal movement during practice. These accounts show energy-related phenomenology may play a meaningful role in contemporary meditation.
The Subjective
Experience of Reiki
This large qualitative study gathered reports from more than one thousand Reiki sessions, finding common experiences such as deep relaxation, bodily sensations, emotional release and shifts in awareness. These recurring accounts offer insight into how people subjectively experience Reiki, providing a phenomenological picture of the inner changes that can accompany biofield-based healing practices.
Subtle Energy in Indo-Tibetan Medicine and Philosophy
This article reviews how South Asian and Himalayan healing systems, including Vedic, Jain, and Tibetan traditions, describe subtle energies and consciousness as part of health, balance, and healing. It explains how these cross cultural frameworks offer long standing accounts of energy and inner experience, suggesting that the biofield concept aligns not only with modern inquiry but also with ancient understandings of healing.
Explore the Science
Browse by Category
Join the Community
For exclusive access to the latest research, resources and stories transforming how we experience healing.
Phenomena Healing was created by the non-profit Merraki Media and the Subtle Energy Funders Collective to thoughtfully explore energy healing, using rigorous scientific inquiry, in an endeavor to help reduce suffering and promote wellbeing. "Merraki" is a Greek word that means “doing something purely for the love of it."
© 2026 Phenomena Healing